The weekly litigation news digest is live. Subscribe now

Phosphorous Derivatives As Kinase Inhibitors - EP2300013

The patent EP2300013 was granted to Ariad Pharmaceuticals on Nov 13, 2024. The application was filed on May 21, 2009 under application number EP09751617A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2300013

ARIAD PHARMACEUTICALS
Application Number
EP09751617A
Filing Date
May 21, 2009
Status
Patent Maintained As Amended
Oct 11, 2024
Publication Date
Nov 13, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKJun 5, 2018ELKINGTON AND FIFEADMISSIBLE

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONFR2911138
EXAMINATIONWO2004080980
EXAMINATIONWO2007021937
INTERNATIONAL-SEARCH-REPORTUS2005203114
INTERNATIONAL-SEARCH-REPORTUS6770652
INTERNATIONAL-SEARCH-REPORTUS6878697
OPPOSITIONFR2911138
OPPOSITIONUS2004242611
OPPOSITIONUS2005203114
OPPOSITIONWO2004080980
OPPOSITIONWO2005016528
OPPOSITIONWO2006078846
OPPOSITIONWO2007006926
OPPOSITIONWO2007021937
SEARCHUS2005203114
SEARCHUS6878697
SEARCHWO2005016528
SEARCHWO2006078846
SEARCHWO2007006926

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents